Abstract
The purpose of the study is to describe what is the presentation of breast cancer in women with HIV, their tolerance to therapy, the most common complications of treatment and their outcomes. Retrospective chart review of patients with HIV diagnosed with breast cancer between January 1, 1989 and December 31, 2013 at the University of Miami/Jackson Memorial Hospital (UM/JMH) 47 females and 1 male were included in the analysis. The median age of diagnosis was 46 years (IQR 41–52) and 64 % of the women were premenopausal. Median CD4+ count was 330 cells/µL (IQR 131–589 cells/µL). 41 % had AIDS at time of diagnosis. 94 % of patients presented with locoregional disease and 6 % with late stage breast cancer. 52 % had ER+ tumors. 6 % had HER-2/neu tumor expression and 21 % had triple negative disease. The 5 year PFS was 50 % (95 % CI 34–64 %), the 5 year OS was 44 % (95 % CI 29–58 %), and the Breast cancer-specific survival was 57 % (95 % CI 40–70 %). Death was attributed to breast cancer in 22 patients, AIDS progression in 6 patients, other medical condition in 1, and for 4, the cause was unknown. Serious adverse events were documented in 46 % of patients treated with chemotherapy. Targeted therapy was well tolerated. Patients with HIV/AIDS and breast cancer pose a major challenge for oncologists. Surgery, radiation, and endocrine therapy are well tolerated. Standard dose chemotherapy can have life-threatening side effects which can be managed with growth factor support and antimicrobial prophylaxis. All cancer therapy can be given while continuing with antiviral therapy at full dose.




Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. New Engl J Med 353(17):1784–1792. doi:10.1056/NEJMoa050518
American Cancer Society (2014) Cancer facts and figures 2014. American Cancer Society, Atlanta
Surveillance, Epidemiology, and End Results Program (SEER); Stat Fact Sheets: Breast Cancer (SEER Cancer Statistics Review, 1975–2010.) National Cancer Institute. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission
Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK, Wegner S (2009) Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS (London, England) 23(1):41–50. doi:10.1097/QAD.0b013e328317cc2d
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 338(13):853–860. doi:10.1056/nejm199803263381301
Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Moller H, Bower M (2009) Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 27(6):884–890. doi:10.1200/jco.2008.19.6626
Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA, J Am Med Assoc 285(13):1736–1745
Amir H, Kaaya EE, Kwesigabo G, Kiitinya JN (2000) Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996. J Natl Med Assoc 92(6):301–305
Pantanowitz L, Dezube BJ (2001) Breast cancer in women with HIV/AIDS. JAMA, J Am Med Assoc 285(24):3090–3091
Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D’Souza G, Greenblatt RM, Goedert JJ (2010) HIV tropism and decreased risk of breast cancer. PLoS ONE 5(12):e14349. doi:10.1371/journal.pone.0014349
Spano JP, Lanoy E, Mounier N, Katlama C, Costagliola D, Heard I (2012) Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications. Eur J Cancer 48(18):3335–3341. doi:10.1016/j.ejca.2012.05.019
Cubasch H, Joffe M, Hanisch R, Schuz J, Neugut AI, Karstaedt A, Broeze N, van den Berg E, McCormack V, Jacobson JS (2013) Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa. Breast Cancer Res Treat 140(1):177–186. doi:10.1007/s10549-013-2606-y
Andrade AC, Luz PM, Veloso VG, Cardoso SW, Moreira RI, Grinsztejn B, Friedman RK (2011) Breast cancer in a cohort of human immunodeficiency virus (HIV)-infected women from Rio de Janeiro, Brazil: a cases series report and an incidence rate estimate. Braz J Infect Dis 15(4):387–393
Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA (2006) Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer 95(5):642–648. doi:10.1038/sj.bjc.6603282
Sarhan M, DePaz HA, Oluwole SF (2010) Breast cancer in women with human immunodeficiency virus infection: pathological, clinical, and prognostic implications. J Women’s Health 19(12):2261–2266. doi:10.1089/jwh.2010.2026
Shaaban HS, Modi Y, Guron G (2012) Is there an association between human immunodeficiency virus infection and breast cancer? Med Oncol 29(2):446–447. doi:10.1007/s12032-011-9856-5
Health DoGWa, World Health Organization (2009) Integrating gender into HIV/AIDS programmes in the health sector: tool to improve responsiveness to women’s needs. Bulletin of the World Health Organization. World Health Organization, Geneva
Hurley J, Franco S, Gomez-Fernandez C, Reis I, Velez P, Doliny P, Harrington W Jr, Wilkinson J, Kanhoush R, Lee Y (2001) Breast cancer and human immunodeficiency virus: a report of 20 cases. Clin Breast Cancer 2(3):215–220. doi:10.3816/CBC.2001.n.024 (discussion 221)
Calabresi A, Ferraresi A, Vavassori A, Castelli F, Quiros-Roldan E (2012) Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. Braz J Infect Dis 16(4):396–397. doi:10.1016/j.bjid.2012.06.001
El-Rayes BF, Berenji K, Schuman P, Philip PA (2002) Breast cancer in women with human immunodeficiency virus infection: implications for diagnosis and therapy. Breast Cancer Res Treat 76(2):111–116
Guth AA (2003) Breast cancer and human immunodeficiency virus infection: issues for the 21st century. J Women’s Health 12(3):227–232. doi:10.1089/154099903321667564
Intra M, Gentilini O, Brenelli F, Chagas EM, Veronesi U, Sandri MT (2005) Breast cancer among HIV-infected patients: the experience of the European Institute of Oncology. J Surg Oncol 91(2):141–142. doi:10.1002/jso.20315
Latif N, Rana F, Guthrie T (2011) Breast cancer and HIV in the era of highly active antiretroviral therapy: two case reports and review of the literature. Breast J 17(1):87–92. doi:10.1111/j.1524-4741.2010.01023.x
Oluwole SF, Ali AO, Shafaee Z, DePaz HA (2005) Breast cancer in women with HIV/AIDS: report of five cases with a review of the literature. J Surg Oncol 89(1):23–27. doi:10.1002/jso.20171
Petoumenos K, Hui E, Kumarasamy N, Kerr SJ, Choi JY, Chen YM, Merati T, Zhang F, Lim PL, Sungkanuparph S, Pujari S, Ponnampalavanar S, Ditangco R, Lee CK, Grulich A, Law MG (2010) Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc 13:51. doi:10.1186/1758-2652-13-51
Mounier N, Katlama C, Costagliola D, Chichmanian RM, Spano JP (2009) Drug interactions between antineoplastic and antiretroviral therapies: implications and management for clinical practice. Crit Rev Oncol/Hematol 72(1):10–20. doi:10.1016/j.critrevonc.2008.10.013
American Cancer Society (2013) Breast cancer facts and figures 2013–2014. Ame Cancer Soc Inc, Atlanta
Shiels MS, Pfeiffer RM, Engels EA (2010) Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 153(7):452–460. doi:10.7326/0003-4819-153-7-201010050-00008
Garcia-Tejedor A, Devesa NR, Suarez-Pumariega P, del Barco S, Huerta MV (2007) Breast cancer and HIV–the adverse effects chemotherapy. Breast J 13(6):622–623. doi:10.1111/j.1524-4741.2007.00498.x
Tolaney SM, Najita J, Winer EP, Burstein HJ (2008) Lymphopenia associated with adjuvant anthracycline/taxane regimens. Clin Breast Cancer 8(4):352–356. doi:10.3816/CBC.2008.n.041
NCHHSTP Atlas. (2010) CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). http://gis.cdc.gov/GRASP/NCHHSTPAtlas/main.html. Accessed 20 May 2014
Number of Reported AIDS and HIV cases in 2011, 2012 and 2013 http://www.dadehealth.org/downloads/Reported%20AIDS%20&%20HIV%20cases%202011-2013.pdf. Accessed 20 May 2014
American Cancer Society (2013) Cancer facts and figures for African Americans 2013–2014. American Cancer Society
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, J Am Med Assoc 295(21):2492–2502. doi:10.1001/jama.295.21.2492
Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol biomark Prev 11(7):601–607
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
This research project complies with the current laws of the US.
Funding sources
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gomez, A., Montero, A.J. & Hurley, J. Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study. Breast Cancer Res Treat 149, 781–788 (2015). https://doi.org/10.1007/s10549-015-3275-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-015-3275-9